Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VTR vs GSK✓SelectedUSD · GSKVTR vs GSK performance historyLatest closeAs of-0.81%11/13
Stock and ETF performance explorer

VTR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,466.8%
GSK return
+356.9%
Excess return
+1,109.9%
Maximum drawdown
-86.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%+0.5%-1.3%-1.0%
7D+0.2%+1.1%-0.9%-0.3%
30D+5.5%+6.3%-0.9%+3.0%
3M-0.9%+1.8%-2.7%-1.9%
6M-0.4%+1.7%-2.1%-1.4%
YTD+17.0%+6.5%+10.5%+13.1%
1Y+18.0%+9.5%+8.5%+12.7%
3Y+127.4%+65.3%+62.1%+80.8%
5Y+92.3%+43.7%+48.5%+58.8%
10Y+129.6%+104.1%+25.5%+66.9%
All+1,466.8%+356.9%+1,109.9%+645.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling